Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1M Sell
158,622
-6,132
-4% -$1.2M 5.97% 7
2025
Q4
$37.1M Sell
164,754
-5,566
-3% -$1.21M 6.68% 4
2025
Q3
$32.4M Buy
170,320
+1,984
+1% +$361K 5.73% 6
2025
Q2
$26.5M Buy
+168,336
New +$25.3M 5.42% 7

Other funds holding IQV

Act Two Investors's IQV Position: Q1 2026 in Review

Act Two Investors reduced its IQVIA (IQV) stake by 3.7% in Q1 2026, selling an estimated $1.2M and leaving 158,622 shares worth $27.1M. The position accounts for 5.97% of the portfolio, ranked #7.

Act Two Investors first reported a position in IQV in Q2 2025 and has held it in 4 quarters since. The position peaked at $37.1M in Q4 2025. 1,067 funds tracked by Wall St. Rank hold IQV as of Q1 2026.

  • Act Two Investors held 158,622 shares of IQVIA worth $27.1M as of Q1 2026.
  • Act Two Investors sold 6,132 IQVIA shares in Q1 2026, an estimated $1.2M.
  • IQVIA made up 5.97% of Act Two Investors's portfolio in Q1 2026, its #7 holding.
  • Act Two Investors first reported a position in IQVIA in Q2 2025 and has held it in 4 quarters since.
  • Act Two Investors's IQVIA position peaked at $37.1M in Q4 2025.
  • 1,067 funds tracked by Wall St. Rank held IQVIA as of Q1 2026.

Based on Act Two Investors's 13F filing for Q1 2026, filed 8 May 2026.